The Food and Drug Administration (FDA) has expanded the approval of Bimzelx (bimekizumab-bkzx) to include 3 new indications.

Formycon AG (“Formycon”) and its commercialization partner Fresenius Kabi (“Fresenius”) jointly announced that the ...

Johnson & Johnson JNJ announced that it has discontinued the phase II field study, which evaluated the company’s ...

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

Psoriatic arthritis is a form of arthritis that often accompanies psoriasis ... it is important that you work with your doctor and health care providers to come up with a treatment plan that works for ...

Machine learning models may be a useful tool for psoriasis severity assessment in clinical settings, despite a need for further research.

Kymera Therapeutics is a biotech company with innovative technology targeting disease-causing proteins, offering promising ...